Some of the major factors driving the growth of advanced wound care market are rising aging population, growing incidences of diabetes, technological advancement, rising awareness regarding new technology, government support in the terms of funding, reduced duration of hospital stays, rising incidence of chronic wounds, problem associated with ineffective traditional wound healing method, increase funding in wound care and development, increasing volume of surgeries across the globe, faster recovery and healing time, range of wound indications at relatively lower prices, innovative products and rising demand in emerging healthcare market. On the other hand, high cost of advanced wound care, low awareness especially in underdeveloped countries shortage of trained staff and facilities in some regions, complex regulatory approval process, reimbursement concerns for new technologies, and competition with other moist dressing may hinder the growth of the market.
Request For Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-advanced-wound-care-market
Scope of the Report:
The global advanced wound care market is segmented into three product types, dressing, biologics, and therapy devices. In 2017, dressing segment is expected to dominate the global advanced wound care market with around 51 percent market share and is expected to dominate in the forecast period 2017 to 2024. However, biologics segment is expected to grow at the highest CAGR in the forecast period.
Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing. In 2017, film dressing segment is expected to dominate the global advanced wound care market.
Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.
Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF).
Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyperbaric oxygen chambers and physical therapies.
Based on NPWT type, the market is segmented into stand-alone NPWT devices, portable NPWT devices and disposable NPWT devices.
Based on PRD type, the market is segmented into mattress and bed.
Based on hyperbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.
Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, and mechanical among others.
Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.
Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, and venous ulcer among others. Diabetic ulcers segment is expected to grow at the highest CAGR of in the forecast period.
On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare. In 2017, hospitals segment is expected to dominate the global advanced wound care market and is expected to dominate in the forecast period 2017 to 2024.
On the basis of distribution channel the market is segmented into direct tenders, and retails.
To Buy Complete Report Click Here @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-advanced-wound-care-market
Some of the major factors driving the growth of advanced wound care market are technological advancement, rising incidences of chronic wound, government support, rising geriatric population, and increasing trend.
1. Increasing prevalence of chronic diseases can be related to lifestyle, such as diabetes and obesity, are one of the fundamental trends which are driving growth of advanced wound care market.
2. The increasing prevalence of chronic wounds is driving demand for products which enhance quality of life and limit the risk of more serious health problems.
3. Willingsford Healthcare a small British company is to receive government grant to develop its innovative wound treatment.
4. Advance wound care is highly used in case of pressure ulcers, diabetic ulcers and chronic ulcers.
Top Key Points:
Acelity L.P. Inc., is going to dominate the advanced wound care market following with 3M, Smith and Nephew, Medtronic, Molnlycke Healthcare AB, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, MiMedx Group, Organo genesis Inc, Talley Group Limited, BSN Medical, Devon Medical Products, Human Biosciences Inc, B. Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, Kinetic Concepts, Advancis Medical.
1. Dressing market is growing with the highest CAGR.
2. Globally Surgical Wound is driving the market with highest market share. However, Diabetic Ulcers is growing with the highest CAGR.
3. Hospital is dominating the global advanced wound care market.
Table of Contents:
1.1. OVERVIEW OF GLOBAL ADVANCED WOUND CARE MARKET
1.2. CURRENCY AND PRICING
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
3. MARKET OVERVIEW
3.1.1. RISING AGING AND GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENT
3.1.3. GOVERNMENT SUPPORT
3.1.4. RISING INCIDENCES OF CHRONIC WOUND
3.1.5. INCREASING TREND
3.2.1. LOW AWARENESS
3.2.2. SLOW GROWTH RATE AND SHRINKING MARKET
3.2.3. COMPLEX REGULATORY APPROVAL PROCESS
3.2.4. COMPETITION WITH OTHER MOIST DRESSINGS
3.3.2. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.3.3. UNMET NEED
3.3.4. INCREASING DEMAN
3.4.1. SHORTAGE OF TRAINED STAFF
3.4.2. THE DEVELOPMENT OF SUBSTITUTE PRODUCTS
3.5. KEY MARKET TRENDS AND UPCOMMING TECHNOLOGIES
3.5.1. SMART DRESSING WILL PUSH FUTURE GROWTH
3.5.2. HYDROFIBER HAS BEEN THE MOST SIGNIFICANT RECENT INNOVATION
3.5.3. ALGINATE DRESSING IS EXPECTED TO GROW ROBUSTLY IN THE UPCOMING YEARS
3.5.4. FOAM DRESSING ACCOUNTING THE LARGEST MARKET SEGMENT IN THE UPCOMING YEARS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
6.4. THERAPY DEVICES
7. GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE
7.2. SURGICAL WOUND
7.2.1. CLASS I
7.2.2. CLASS II
7.2.3. CLASS III
7.2.4. CLASS IV
7.3. DIABETIC ULCERS
7.4. PRESSURE ULCERS
7.5. VENOUS ULCERS
8. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER
9. GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
10. GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
10.2. NORTH AMERICA ADVANCED WOUND CARE MARKET
10.2.1. U.S. ADVANCED WOUND CARE MARKET
10.2.2. CANADA ADVANCED WOUND CARE MARKET
10.2.3. MEXICO ADVANCED WOUND CARE MARKET
10.3. APAC ADVANCED WOUND CARE MARKET
10.3.1. JAPAN ADVANCED WOUND CARE MARKET
10.3.2. CHINA ADVANCED WOUND CARE MARKET
10.3.3. SOUTH KOREA ADVANVCED WOUND CARE MARKET
10.3.4. INDIA ADVANCED WOUND CARE MARKET
10.3.5. AUSTRALIA ADVANCED WOUND CARE MARKET
10.3.6. THAILAND ADVANCED WOUND CARE MARKET
10.3.7. SINGAPORE ADVANCED WOUND CARE MARKET
10.3.8. MALAYSIA ADVANVCED WOUND CARE MARKET
10.3.9. PHILIPPINESADVANCED WOUND CARE MARKET
10.3.10. INDONESIA ADVANCED WOUND CARE MARKET
10.3.11. REST OF APAC ADVANCE WOUND CARE MARKET
10.4. SOUTH AMERICA ADVANCED WOUND CARE MARKET
10.4.1. BRAZIL ADVANCED WOUND CARE MARKET
10.4.2. REST OF SOUTH AMERICA ADVANCED WOUND CARE MARKET
10.5. EUROPE ADVANCED WOUND CARE MARKET
10.5.1. GERMANY ADVANCED WOUND CARE MARKET
10.5.2. FRANCE ADVANCED WOUND CARE MARKET
10.5.3. U.K. ADVANCED WOUND CARE MARKET
10.5.4. ITALY ADVANCED WOUND CARE MARKET
10.5.5. SPAIN ADVANCED WOUND CARE MARKET
10.5.6. SWITZERLAND ADVANCED WOUND CARE MARKET
10.5.7. NETHERLANDS ADVANCED WOUND CARE MARKET
10.5.8. RUSSIA ADVANCED WOUND CARE MARKET
10.5.9. BELGIUM ADVANCED WOUND CARE MARKET
10.5.10. TURKEY ADVANCED WOUND CARE MARKET
10.5.11. REST OF EUROPE ADVANCED WOUND CARE MARKET
10.6. MEA ADVANCED WOUND CARE MARKET
10.6.1. SOUTH AFRICA ADVANCED WOUND CARE MARKET
10.6.2. SAUDI ARABIA ADVANCED WOUND CARE MARKET
10.6.3. UAE ADVANCED WOUND CARE MARKET
10.6.4. REST OF MEA ADVANCED WOUND CARE MARKET
11. GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA
12. COMPANY PROFILES
12.1. ACELITY L.P. INC.
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. SMITH AND NEPHEW
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. MOLNLYCKE HEALTHCARE
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLI
12.3.4. RECENT DEVELOPMENTS
12.4. CONVATEC INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTF
12.4.4. RECENT DEVELOPMENTS
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. ETHICON INC
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. INTEGRA LIFE SCIENCES CORPORATION
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. DERMA SCIENCES INC
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. RECENT DEVELOPMENTS
12.11. PAUL HARTMANN LIMITED
12.11.1. COMPANY OVERVIEW
12.11.2. REVENUE ANALYSIS
12.11.3. PRODUCT PORTFOLIO
12.12. ORGANOGENESIS INC
12.12.1. COMPANY OVERVIEW
12.12.2. REVENUE ANALYSIS
12.12.3. PRODUCT PORTFOLIO
12.12.4. RECENT DEVELOPMENTS
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar